Rani Therapeutics Holdings, Inc. SEC filings RANI
Rani Therapeutics Holdings, Inc. has 380 filings in SEC EDGAR's recent list, going back to Apr 27, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 15, 2026 | — |
| 424B5 | Prospectus supplement | May 27, 2026 | — |
| S-8 | Employee stock plan registration | Mar 26, 2026 | — |
| 424B5 | Prospectus supplement | Dec 3, 2025 | — |
| S-3 | Shelf registration | Nov 7, 2025 | — |
| S-3 | Shelf registration | Aug 8, 2025 | — |
| 424B5 | Prospectus supplement | Jul 16, 2025 | — |
| 424B5 | Prospectus supplement | Jul 11, 2025 | — |
| S-3 | Shelf registration | Jul 3, 2025 | — |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 424B5 | Prospectus supplement | Oct 16, 2024 | — |
| 424B5 | Prospectus supplement | Jul 23, 2024 | — |
| S-8 | Employee stock plan registration | Mar 20, 2024 | — |
| S-8 | Employee stock plan registration | Mar 22, 2023 | — |
| 424B7 | Filing | Dec 29, 2022 | — |
| S-3 | Shelf registration | Dec 16, 2022 | — |
| 424B5 | Prospectus supplement | Aug 25, 2022 | — |
| 424B5 | Prospectus supplement | Aug 11, 2022 | — |
| S-3 | Shelf registration | Aug 1, 2022 | — |
| S-8 | Employee stock plan registration | Mar 31, 2022 | — |
| S-8 | Employee stock plan registration | Aug 3, 2021 | — |
| 424B4 | Prospectus | Aug 2, 2021 | — |
| FWP | Free writing prospectus | Jul 30, 2021 | — |
| S-1/A | Amended registration statement | Jul 26, 2021 | — |
| S-1/A | Amended registration statement | Jul 16, 2021 | — |
| S-1 | Registration statement | Jul 9, 2021 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RANI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CA
- Headquarters
- San Jose, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1856725
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.